APA (7th ed.) Citation

N, M., J, C., P, L., F, K., OM, W., C, K., . . . A, I. (2026). Clinical validation of T1ρ mapping for the assessment of hepatic fibrosis in patients with chronic liver disease. European radiology, 36(5), 3983. https://doi.org/10.1007/s00330-025-12225-5

Chicago Style (17th ed.) Citation

N, Mesropyan, et al. "Clinical Validation of T1ρ Mapping for the Assessment of Hepatic Fibrosis in Patients with Chronic Liver Disease." European Radiology 36, no. 5 (2026): 3983. https://doi.org/10.1007/s00330-025-12225-5.

MLA (9th ed.) Citation

N, Mesropyan, et al. "Clinical Validation of T1ρ Mapping for the Assessment of Hepatic Fibrosis in Patients with Chronic Liver Disease." European Radiology, vol. 36, no. 5, 2026, p. 3983, https://doi.org/10.1007/s00330-025-12225-5.